Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID‑19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. From Wikipedia
New research shows the antiviral drug does not significantly reduce COVID-19 hospitalizations or mortality in vaccinated adults over 70.
